F. Koppe

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

A. Stiggelbout, E. Schaake, J. Beukema, 2021, Gynecologic oncology.

Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.

S. Senan, F. Wenz, A. Brade, 2018, International journal of radiation oncology, biology, physics.

Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

H. Putter, T. Bosse, D. Cibula, 2020, International Journal of Gynecological Cancer.

The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.

B. Heijmen, K. Muller, H. Ceha, 2020, International journal of radiation oncology, biology, physics.

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.

E. M. van der Steen-Banasik, H. Westerveld, M. Nowee, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.

P. Lambin, L. Boersma, D. de Ruysscher, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.

P. Lambin, L. Boersma, D. de Ruysscher, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Neuro-cognitive (HVLT-R total recall) functioning in localized vs. metastatic small-cell lung cancer with or without hippocampus sparing PCI: Results from a phase III trial

D. Ruysscher, K. Sikorska, E. Dieleman, 2019, Lung cancer.

Determinants of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients

J. Bussink, J. Belderbos, J. Widder, 2015 .

OC-0503 Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC

K. Sikorska, S. Deprez, J. Belderbos, 2019, Radiotherapy and Oncology.

Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675).

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.